Biggest News Aggregation in the World
๐Ÿ“ฐ Compugen Ltd News

Page 2 - Compugen Ltd News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Compugen Ltd. Real-time updates on events, politics, business and more.

Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the appointment of Michelle Mahler, M.D., as Chief Medical Officer, effective March 1, 2024. Michelle will succeed Henry Adewoye, M.D., who is leaving Compugen to pursue other opportunities effective February 29, 2024, after 6 years with Compugen.
South Africa Tel Aviv Memorial Sloan Kettering Cancer Center New York United States New York Presbyterian Hospital
Source: yahoo.com

Compugen (NASDAQ:CGEN) Downgraded by StockNews.com

StockNews.com cut shares of Compugen (NASDAQ:CGEN – Free Report) from a hold rating to a sell rating in a research note released on Thursday. Separately, Stifel Nicolaus upped their price objective on shares of Compugen from $3.00 to $4.00 and gave the company a buy rating in a report on Tuesday, December 19th. Two analysts […]
United States Stifel Nicolaus Goldman Sachs Group Inc Kingsview Wealth Management Compugen Company Profile Compugen Ltd

Compugen Ltd. (NASDAQ:CGEN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Compugen Ltd. (NASDAQ:CGEN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 1 year target […]
United States Stifel Nicolaus Sphera Funds Management Compugen Ltd Silverarc Capital Management Renaissance Technologies

Compugen To Receive $10 Mln Payment After Dosing First Patient In AstraZeneca's ARTEMIDE-Bil01 Trial

Cancer immunotherapy company Compugen Ltd. (CGEN) announced Monday that Compugen is entitled to receive a $10 million milestone payment from British drug major AstraZeneca (AZN), after the first patient was dosed in AstraZeneca's ARTEMIDE-Bil01 trial with rilvegostomig.
United Kingdom Compugen Ltd Drug Major Astrazeneca Ancer Immunotherapy Company Compugen

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Brokerages Set Compugen Ltd. (NASDAQ:CGEN) Price Target at $5.33

Compugen Ltd. (NASDAQ:CGEN – Get Free Report) has received an average rating of “Moderate Buy” from the five brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have assigned a buy recommendation to the company. The average 12 month price […]
United States Stifel Nicolaus Envestnet Asset Management Inc Compugen Ltd Geode Capital Management Virtu Financial

Compugen joins a $848M collaboration with Gilead

Compugen Ltd. has entered another collaboration, this time exclusively licensing a preclinical antibody program against an IL-18 binding protein with Gilead Sciences Inc. Compugen will handle ongoing preclinical development and a phase I study of COM-503 to treat tumors, then Gilead receives to sole right to further continue developing the asset. Compugen is getting an up-front $60 million and is eligible for a $30 million milestone payment should the IND clear in 2024. Compugen also is eligible...
Compugen Ltd Gilead Sciences Inc Gilead Sciences Compugen Ltd Gilead Sciences Inc Com 503

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, headquartered in Holon, Israel, to exclusively license its potential first-in-class, pre-clinical antibody ...
Foster City United States Israel General San Francisco Tel Aviv Flavius Martin

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science